FDA Introduces Innovative Proposal to Advance Consumer Access to Nonprescription Drugs
http://www.fda.gov/news-events/press-announcements/fda-introduces-innovative-proposal-advance-consumer-access-nonprescription-drugs

FDA Infant Formula Update: June 27, 2022
http://www.fda.gov/news-events/press-announcements/fda-infant-formula-update-june-27-2022

FDA Roundup: June 24, 2022
http://www.fda.gov/news-events/press-announcements/fda-roundup-june-24-2022

FDA Releases Action Plan for Rare Neurodegenerative Diseases, Including ALS
http://www.fda.gov/news-events/press-announcements/fda-releases-action-plan-rare-neurodegenerative-diseases-including-als

FDA Denies Authorization to Market JUUL Products
http://www.fda.gov/news-events/press-announcements/fda-denies-authorization-market-juul-products

http://www.fda.gov/medical-devices/medical-device-recalls/baxter-healthcare-corporation-recalls-volara-system-risk-respiratory-distress-ventilated-patients

http://www.fda.gov/medical-devices/medical-device-recalls/medtronic-recalls-heartware-hvad-system-batteries-due-battery-failure

FDA Infant Formula Update: June 22, 2022
http://www.fda.gov/news-events/press-announcements/fda-infant-formula-update-june-22-2022

FDA Provides Update on Efforts to Increase Supply and Availability of Safe and Nutritious Infant Formula
http://www.fda.gov/news-events/press-announcements/fda-provides-update-efforts-increase-supply-and-availability-safe-and-nutritious-infant-formula

http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/bd-announces-voluntary-recall-intraosseous-products